DK361483D0 - Gaerhybridvektorer samt deres anvendelse ved fremstilling af polypeptider - Google Patents
Gaerhybridvektorer samt deres anvendelse ved fremstilling af polypeptiderInfo
- Publication number
- DK361483D0 DK361483D0 DK3614/83A DK361483A DK361483D0 DK 361483 D0 DK361483 D0 DK 361483D0 DK 3614/83 A DK3614/83 A DK 3614/83A DK 361483 A DK361483 A DK 361483A DK 361483 D0 DK361483 D0 DK 361483D0
- Authority
- DK
- Denmark
- Prior art keywords
- hybrid vectors
- yeast
- promoter
- preparing polypeptides
- year hybrid
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title abstract 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 108010051457 Acid Phosphatase Proteins 0.000 abstract 1
- 208000031295 Animal disease Diseases 0.000 abstract 1
- 108091026890 Coding region Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 238000000844 transformation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Alcoholic Beverages (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8222883 | 1982-08-09 | ||
| GB8222883 | 1982-08-09 | ||
| GB8237026 | 1982-12-31 | ||
| GB8237026 | 1982-12-31 | ||
| GB838315145A GB8315145D0 (en) | 1982-08-09 | 1983-06-02 | Yeast hybrid vectors |
| GB8315145 | 1983-06-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK361483D0 true DK361483D0 (da) | 1983-08-08 |
| DK361483A DK361483A (da) | 1984-02-10 |
| DK174905B1 DK174905B1 (da) | 2004-02-16 |
Family
ID=27261693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198303614A DK174905B1 (da) | 1982-08-09 | 1983-08-08 | DNA-sekvens og fremgangsmåde til den fremstilling, gærhybridvektorer og Saccharomyces cerevisiae indeholdende sekvensen henholdsvis vektoren og fremgangsmåder til deres fremstilling samt deres anvendelse ved fremstilling af polypeptider |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0100561B1 (da) |
| JP (2) | JPH0653073B2 (da) |
| AT (1) | ATE43636T1 (da) |
| AU (1) | AU566348B2 (da) |
| CA (1) | CA1341381C (da) |
| CY (1) | CY1451A (da) |
| DD (1) | DD218118A5 (da) |
| DE (1) | DE3379960D1 (da) |
| DK (1) | DK174905B1 (da) |
| ES (3) | ES8505724A1 (da) |
| FI (1) | FI80720C (da) |
| GB (1) | GB2125047B (da) |
| GR (1) | GR78924B (da) |
| HK (1) | HK90688A (da) |
| HU (1) | HU204095B (da) |
| IE (1) | IE55598B1 (da) |
| NO (1) | NO172548C (da) |
| NZ (1) | NZ205178A (da) |
| PH (1) | PH25617A (da) |
| PT (1) | PT77167B (da) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2125047B (en) * | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
| DE3381619D1 (de) * | 1982-08-16 | 1990-07-05 | Chemo Sero Therapeut Res Inst | Pendelvektor. |
| JPS5936699A (ja) * | 1982-08-20 | 1984-02-28 | Chemo Sero Therapeut Res Inst | シヤトルベクタ− |
| JPS5931799A (ja) * | 1982-08-16 | 1984-02-20 | Science & Tech Agency | B型肝炎ウイルス遺伝子を組込んだ組換えプラスミド |
| AU584580B2 (en) * | 1982-09-08 | 1989-06-01 | Smith Kline - Rit | Hepatitis B virus vaccine |
| JPS5974988A (ja) * | 1982-10-20 | 1984-04-27 | Suntory Ltd | 酵母の誘導発現型プラスミドベクタ−およびその利用方法 |
| ZA843275B (en) * | 1983-05-05 | 1984-12-24 | Hoffmann La Roche | Novel vectors for interferon expression |
| FI86746C (fi) * | 1983-11-21 | 1992-10-12 | Ciba Geigy Ag | Foerfarande foer framstaellning av maensklig vaevnads-plasminogenaktivator (tpa) med hjaelp av saccharomyces cerevisiae -jaest och i foerfarandet anvaenda hybridvektorer |
| JPS60248181A (ja) * | 1984-05-23 | 1985-12-07 | Shiseido Co Ltd | 酵母発現ベクタ− |
| AU600885B2 (en) * | 1984-05-25 | 1990-08-30 | Zymogenetics Inc. | Stable DNA constructs |
| US5723292A (en) * | 1984-05-25 | 1998-03-03 | Zymogenetics, Inc. | Stable DNA constructs |
| GB8415186D0 (en) * | 1984-06-14 | 1984-07-18 | Ciba Geigy Ag | Polypeptides |
| JPS61502795A (ja) * | 1984-07-09 | 1986-12-04 | レモント,ジェフリ−・エフ | 酵母クロ−ニング ビ−クル |
| JPS61502655A (ja) * | 1984-07-09 | 1986-11-20 | インテグレ−テッド・ジェネティックス・インコ−ポレ−テッド | 酵母クロ−ニングビヒクル |
| JPS61503002A (ja) * | 1984-07-31 | 1986-12-25 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | 酵母クロ−ニングベクタ− |
| JPS61103895A (ja) * | 1984-10-26 | 1986-05-22 | Green Cross Corp:The | HBsAgの精製方法 |
| US5336609A (en) * | 1984-12-06 | 1994-08-09 | Labofina, S.A. | Transformed yeasts for producing lysozyme, plasmids used for this transformation, method of producing lysozyme |
| EP0194006B1 (en) * | 1985-02-01 | 1992-04-29 | Imperial Chemical Industries Plc | Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them |
| GB8521496D0 (en) * | 1985-08-29 | 1985-10-02 | Ciba Geigy Ag | Repressible yeast promoters |
| JPS62151183A (ja) * | 1985-09-18 | 1987-07-06 | Green Cross Corp:The | 酵母プロモ−タ−及び異種蛋白質の製造方法 |
| EP0216573B1 (en) * | 1985-09-18 | 1990-11-22 | Green Cross Corporation | Yeast promoter and method of producing heterologous proteins |
| GB8530631D0 (en) | 1985-12-12 | 1986-01-22 | Ciba Geigy Ag | Thrombin inhibitors |
| GB2188049B (en) * | 1986-03-15 | 1990-09-05 | Ciba Geigy Ag | Insecticidal proteinaceous substance |
| EP0240224A3 (en) * | 1986-03-31 | 1989-02-01 | Interferon Sciences, Inc. | An alpha interferon analogue |
| US4857467A (en) * | 1986-07-23 | 1989-08-15 | Phillips Petroleum Company | Carbon and energy source markers for transformation of strains of the genes Pichia |
| DE3789413T2 (de) | 1986-10-03 | 1994-07-28 | Ciba Geigy Ag | Lymphokin-ähnliche Peptide. |
| US5013652A (en) * | 1986-10-14 | 1991-05-07 | Genex Corporation | Composite yeast vectors |
| US5180667A (en) * | 1988-03-07 | 1993-01-19 | Ciba-Geigy Corporation | Genes encoding eglin C mutants |
| DE58907373D1 (de) * | 1988-03-07 | 1994-05-11 | Ciba Geigy | Modifizierte Proteine. |
| DE68928124T2 (de) | 1988-09-02 | 1997-10-16 | Chiron Corp., Emeryville, Calif. | Makrophagenabgeleiteter entzündungsmediator(mip-2) |
| JPH02145193A (ja) * | 1988-11-19 | 1990-06-04 | Lotte Confectionery Co Ltd | 遺伝子の組換えによる酵母でのヒト・アルファ・インターフェロンの製造方法 |
| AU648214B2 (en) * | 1991-12-31 | 1994-04-14 | Lucky Limited | Recombinant gene coding for human alpha interferon and expression vector thereof, etc. |
| DE69434492T2 (de) | 1993-03-10 | 2006-07-13 | Smithkline Beecham Corp. | Phosphodiesterase des menschlichen gehirns |
| US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
| DE60335497D1 (de) | 2002-09-13 | 2011-02-03 | Cornell Res Foundation Inc | Ergillus-phytasen |
| DE102005030552B4 (de) * | 2005-06-22 | 2009-05-28 | Eucodis Bioscience | Selektion von Phosphatase-Aktivität |
| CN102059495A (zh) * | 2010-11-06 | 2011-05-18 | 中国长江航运集团宜昌船厂 | 一种船体框架胎模及加工方法 |
| CN105821078A (zh) | 2010-12-09 | 2016-08-03 | 巴斯德研究所 | 用于获得高产量重组蛋白表达的基于mgmt的方法 |
| WO2013059507A1 (en) | 2011-10-20 | 2013-04-25 | University Of Iowa Research Foundation | N-demethyase genes and uses thereof |
| BR112014013745B1 (pt) | 2011-12-09 | 2022-06-14 | Institut Pasteur | Método de teste in vitro, kit de detecção e seu uso, método in vitro de diagnóstico, método de fabricação de kit, e teste de imunosseleção multiplex |
| US20150184166A1 (en) | 2012-06-15 | 2015-07-02 | Uinversity of Iowa Research Foundation | Caffeine responsive promoters and regulatory genes |
| WO2022049409A1 (en) | 2020-09-02 | 2022-03-10 | Sia Terragen | Express diagnosticum for sars-cov-2 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2458585A1 (fr) * | 1979-06-07 | 1981-01-02 | Pasteur Institut | Procede de production de proteines par expression des genes correspondants dans des micro-organismes et vecteurs susceptibles d'etre mis en oeuvre dans de tels procedes |
| AU546577B2 (en) * | 1980-02-25 | 1985-09-05 | Trustees Of Columbia University, The | Use of eucaryotic promoter sequences in the production of proteinaceous materials |
| IL63270A0 (en) * | 1980-08-05 | 1981-10-30 | Univ Leland Stanford Junior | Eukaryotic autonomously replicating segment |
| IL63035A (en) * | 1980-09-09 | 1985-05-31 | Univ California | Dnas capable of replication and stable mitotic maintenance in a host eukaryote,their preparation and eukaryotic cells comprising them |
| NZ199722A (en) * | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
| US4615974A (en) * | 1981-08-25 | 1986-10-07 | Celltech Limited | Yeast expression vectors |
| NZ201705A (en) * | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| GB2125047B (en) * | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
| JPS5931799A (ja) * | 1982-08-16 | 1984-02-20 | Science & Tech Agency | B型肝炎ウイルス遺伝子を組込んだ組換えプラスミド |
-
1983
- 1983-07-14 GB GB08319099A patent/GB2125047B/en not_active Expired
- 1983-08-05 FI FI832825A patent/FI80720C/fi not_active IP Right Cessation
- 1983-08-08 NZ NZ205178A patent/NZ205178A/en unknown
- 1983-08-08 GR GR72168A patent/GR78924B/el unknown
- 1983-08-08 HU HU832799A patent/HU204095B/hu unknown
- 1983-08-08 AU AU17682/83A patent/AU566348B2/en not_active Expired
- 1983-08-08 CA CA000617149A patent/CA1341381C/en not_active Expired - Fee Related
- 1983-08-08 AT AT83107804T patent/ATE43636T1/de not_active IP Right Cessation
- 1983-08-08 NO NO832848A patent/NO172548C/no not_active IP Right Cessation
- 1983-08-08 DK DK198303614A patent/DK174905B1/da not_active IP Right Cessation
- 1983-08-08 EP EP83107804A patent/EP0100561B1/en not_active Expired
- 1983-08-08 PT PT77167A patent/PT77167B/pt unknown
- 1983-08-08 ES ES524816A patent/ES8505724A1/es not_active Expired
- 1983-08-08 DE DE8383107804T patent/DE3379960D1/de not_active Expired
- 1983-08-08 IE IE1860/83A patent/IE55598B1/en not_active IP Right Cessation
- 1983-08-09 DD DD83253824A patent/DD218118A5/de not_active IP Right Cessation
- 1983-08-09 JP JP58144542A patent/JPH0653073B2/ja not_active Expired - Lifetime
- 1983-08-09 PH PH29374A patent/PH25617A/en unknown
-
1985
- 1985-03-01 ES ES540881A patent/ES8607026A1/es not_active Expired
- 1985-03-01 ES ES540880A patent/ES8607391A1/es not_active Expired
-
1988
- 1988-11-10 HK HK906/88A patent/HK90688A/xx not_active IP Right Cessation
-
1989
- 1989-03-10 CY CY1451A patent/CY1451A/en unknown
-
1990
- 1990-12-28 JP JP2419332A patent/JPH0813277B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK361483A (da) | Gaerhybridvektorer samt deres anvendelse ved fremstilling af polypeptider | |
| BR8206068A (pt) | Composicoes de materia,polipeptideo,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,extrato de cultura celular,cultura de celulas transformantes,uso de interferon imune humano maduro,processo de expressao de um gene,processo para producao de um polipeptideo,processo para producao de um veiculo de expressao,e produto obtido por tais processos | |
| EG19101A (en) | Process for preparing of expression of human proapolipoprotein A.1. | |
| BR8200191A (pt) | Celula viva renina preprorrenina prorrenina processo para obter expressao de preporrenina prorrenina e renina gene de prorrenina preprorrenina e renina e coli material dna recombinador saccharomyces cerevisiae polipetidio processo para exprimir um gene | |
| YU44186B (en) | Process for obtaining recombinant dnk molecules | |
| ATE192500T1 (de) | Rekombinante viren vektoren zur expression in muskelzellen | |
| EP0483115A3 (en) | Regulatory region for heterologous gene expression in yeast | |
| DK163937B (da) | Strukturelt gen, som koder for autentisk humant serumalbumin til ekspression i en ikke-human vaert, fremgangsmaade til fremstilling deraf, rekombinant-dna-molekyle indeholdende genet, vaertsorganisme transformeret dermed og fremgangsmaade til fremstilling af autentisk humant serumalbumin | |
| DE69028499D1 (de) | Neues Verfahren zur Produktion von nichtfusioniertem Protein in E. coli | |
| EP0395706A4 (en) | Production of gonorrheal pi proteins and vaccines | |
| ATE82985T1 (de) | Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung. | |
| EP0222279A3 (en) | Production of active proteins containing cystine residues | |
| AU7949991A (en) | Cloned n-methylhydantoinase | |
| EP0072541A3 (en) | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
| GR3020035T3 (en) | Mammalian cell derived autonomously replicating sequence DNA fragments having affinity to DNA binding proteins | |
| ATE87977T1 (de) | Herstellung menschlichen somatomedins c. | |
| AU1321988A (en) | The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein | |
| DE3853590D1 (de) | Rinder granulocyt-makrophagenkolonie stimulierender faktor. | |
| EP0323838A3 (de) | Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |